Prognostic	O
significance	O
of	O
TRAIL	O
signaling	O
molecules	O
in	O
stage	B-Cancer
II	I-Cancer
and	I-Cancer
III	I-Cancer
colorectal	I-Cancer
cancer	I-Cancer
.	O

PURPOSE	O
:	O

We	O
previously	O
found	O
that	O
cellular	O
FLICE	O
-	O
inhibitory	O
protein	O
(	O
c	O
-	O
FLIP	O
)	O
,	O
caspase	O
8	O
,	O
and	O
tumor	O
necrosis	O
factor	O
-	O
related	O
apoptosis	O
-	O
inducing	O
ligand	O
(	O
TRAIL	O
)	O
receptor	O
2	O
(	O
DR5	O
)	O
are	O
major	O
regulators	O
of	O
cell	B-Cell
viability	O
and	O
chemotherapy	O
-	O
induced	O
apoptosis	O
in	O
colorectal	B-Cancer
cancer	I-Cancer
.	O

In	O
this	O
study	O
,	O
we	O
determined	O
the	O
prognostic	O
significance	O
of	O
c	O
-	O
FLIP	O
,	O
caspase	O
8	O
,	O
TRAIL	O
and	O
DR5	O
expression	O
in	O
tissues	B-Tissue
from	O
patients	O
with	O
stage	B-Cancer
II	I-Cancer
and	I-Cancer
III	I-Cancer
colorectal	I-Cancer
cancer	I-Cancer
.	O

EXPERIMENTAL	O
DESIGN	O
:	O

Tissue	B-Tissue
microarrays	O
were	O
constructed	O
from	O
matched	O
normal	O
and	O
tumor	B-Tissue
tissue	I-Tissue
derived	O
from	O
patients	O
(	O
n	O
=	O
253	O
)	O
enrolled	O
in	O
a	O
phase	O
III	O
trial	O
of	O
adjuvant	O
5	O
-	O
fluorouracil	O
-	O
based	O
chemotherapy	O
versus	O
postoperative	O
observation	O
alone	O
.	O

TRAIL	O
,	O
DR5	O
,	O
caspase	O
8	O
,	O
and	O
c	O
-	O
FLIP	O
expression	O
levels	O
were	O
determined	O
by	O
immunohistochemistry	O
.	O

RESULTS	O
:	O

Colorectal	B-Cancer
tumors	I-Cancer
displayed	O
significantly	O
higher	O
expression	O
levels	O
of	O
c	O
-	O
FLIP	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
,	O
caspase	O
8	O
(	O
P	O
=	O
0	O
.	O
01	O
)	O
,	O
and	O
DR5	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
,	O
but	O
lower	O
levels	O
of	O
TRAIL	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
compared	O
with	O
matched	O
normal	O
tissue	B-Tissue
.	O

In	O
univariate	O
analysis	O
,	O
higher	O
TRAIL	O
expression	O
in	O
the	O
tumor	B-Cancer
was	O
associated	O
with	O
worse	O
overall	O
survival	O
(	O
P	O
=	O
0	O
.	O
026	O
)	O
,	O
with	O
a	O
trend	O
to	O
decreased	O
relapse	O
-	O
free	O
survival	O
(	O
RFS	O
;	O
P	O
=	O
0	O
.	O
06	O
)	O
,	O
and	O
higher	O
tumor	B-Cancer
c	O
-	O
FLIP	O
expression	O
was	O
associated	O
with	O
a	O
significantly	O
decreased	O
RFS	O
(	O
P	O
=	O
0	O
.	O
015	O
)	O
.	O

Using	O
multivariate	O
predictive	O
modeling	O
for	O
RFS	O
in	O
all	O
patients	O
and	O
including	O
all	O
biomarkers	O
,	O
age	O
,	O
treatment	O
,	O
and	O
stage	O
,	O
we	O
found	O
that	O
the	O
model	O
was	O
significant	O
when	O
the	O
mean	O
tumor	B-Cancer
c	O
-	O
FLIP	O
expression	O
score	O
and	O
disease	O
stage	O
were	O
included	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

As	O
regards	O
overall	O
survival	O
,	O
the	O
overall	O
model	O
was	O
predictive	O
when	O
both	O
TRAIL	O
expression	O
and	O
disease	O
stage	O
were	O
included	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

CONCLUSIONS	O
:	O

High	O
c	O
-	O
FLIP	O
and	O
TRAIL	O
expression	O
may	O
be	O
independent	O
adverse	O
prognostic	O
markers	O
in	O
stage	B-Cancer
II	I-Cancer
and	I-Cancer
III	I-Cancer
colorectal	I-Cancer
cancer	I-Cancer
and	O
might	O
identify	O
patients	O
most	O
at	O
risk	O
of	O
relapse	O
.	O

